Importantly, GNMT mRNA levels were significantly lower in prostate tumors with PTEN deletion in two independent prostate cancer datasets [6, 38], thus supporting the results of our mouse model (Fig. 1B). This evidence concerns the gene PTEN and prostate carcinoma.